Clinical Trial Update: CM-101 in NASH Patients - The SPLASH Study [Phase 2]

View source ↗

Summary

Phase 2 trial update for CM-101 in nonalcoholic steatohepatitis (NASH) from the SPLASH study; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• CM-101

Snippet

Sponsor: ChemomAb Ltd. | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED